baber/WOPTO huggingface dataset:
Patent NZ-525576-A (NZ)
Title: Novel glucose dehydrogenase and process for producing the dehydrogenase
Inventor: SODE KOJI
IPC: C12N15/53
Filed: 2001-10-31
Abstract: A method for producing glucose dehydrogenase comprising the steps of culturing a microorganism belonging to the genus Burkhorderia and having glucose dehydrogenase producing ability in a medium, and collecting glucose dehydrogenase from the medium and/or cells of the microorganism.
Patent NZ-525836-A (NZ)
Title: Novel anticholinergic agents that can be used as medicaments and method for the production thereof
Inventor: MEISSNER HELMUT
IPC: A61K31/46
Filed: 2001-09-28
Abstract: - Compounds of formula 1 where: o A denotes a double bonded group selected from formula 2 and 3; and o X- denotes an anion with a single negative charge selected from among chloride, bromide, methylsulphate, 4-toluenesulpohonate and methanesulphonate; and o R1 and R2 which may be identical or different denote a group selected from among methyl, ethyl, n-propyl and isopropyl, which may optionally be substituted by hydroxyl or fluorine; and o R 3 R4, R5 and R6 which may be identical or different, denote hydrogen, methyl, ethyl, methoxy, ethyloxy, hydroxyl, fluorine, chlorine, bromine, CN, CF3 or NO2; o R7 denotes methyl, ethyl, methyloxy, ethyloxy, -CH2-F, -CH2-CH2-F, -O-CH2-F, -O-CH2-CH2OMe, -CH2-OEt, -CH2-CH2-OEt, -O-COMe, -O-COEt, -O-COCF3, -O-COCF3, fluorine, chlorine or bromine. - The use of compounds of formula 1 to treat asthma, COPD, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal tract, spasms in the urinary tract and menstrual disorders. - Pharmaceutical preparations of compounds of formula 1 may also be combined with other drugs such as betamimetics, antiallergic agents, PAF-antagonists, leukotriene-antagonists and steroids. - A process for the production of compounds of formula 1 is also disclosed.
Patent NZ-526532-A (NZ)
Title: The use of substituted azetidinone compounds for the treatment of sitosterolemia
Inventor: DAVIS HARRY R
IPC: A61P9/04
Filed: 2002-01-25
Abstract: Disclosed herein is the use of sterol absorption inhibiting compounds, pharmaceutical compositions thereof, therapeutic combinations and their use in combination with other lipid lowering agents to treat or prevent sitosterolemia and/or to lower the concentration of sterol(s) other than cholesterol in plasma or tissue of a mammal. Methods of treating or preventing vascular disease and coronary events also are described.
Patent NZ-535469-A (NZ)
Title: Amplification-hybridisation method for detecting and typing human papillomavirus
Inventor: JENEY CSABA
IPC: C12Q1/68
Filed: 2003-03-10
Abstract: Disclosed is an amplication primer-mixture, wherein the mixture consists of SEQ ID NOs 73-75, SEQ ID NOs 37-40 and SEQ ID NO: 35 and optionally one or more primers selected from the group consisting of SEQ ID NOs 70-72, SEQ ID NOs 1-34 and 36. Also disclosed is amplification and hybridisation method for detecting and typing human papillomavirus (HPV).
Patent NZ-536450-A (NZ)
Title: Increasing the bioavailability and tissue penetration of azithromycin using p-glycoproteins (p-gp) inhibitor (eg nifedipine, tamoxifen etc)
Inventor: CURATOLO WILLIAM JOHN
IPC: A61K45/00
Filed: 2001-02-22
Abstract: Disclosed herein is a method, wherein the bioavailability of azithromycin can be increased by co-administering azithromycin with a p-glycoprotein (p-gp) inhibitor such as a block co-polymers of poly(propylene oxide) and poly(ethylene oxide). The azithromycin and p-gp inhibitor can be administered together in a composition or as separate components. If administered separately, they can be embodied as a kit.
Patent NZ-537293-A (NZ)
Title: Methods for preparing ethers, halogenated ethers, fluoroethers as well as uses of the latter in fire extinguishing systems
Inventor: CHIEN JOHN
IPC: A62D1/08
Filed: 2003-06-19
Abstract: Described herein are highly fluorinated, saturated, and unsaturated fluoroethers that are efficient, economical, non-ozone-depleting fire extinguishing agents used alone or in blends with other fire extinguishing agents in total flooding and portable systems. Methods for producing ethers, halogenated ether intermediates, and fluoroethers; fluoroether compositions; and fluoroether extinguishing mixtures, methods, and systems are also described. Particularly disclosed is a fire extinguishing, preventing or suppressing system configured to introduce to a space a mixture comprising an extinguishing compound having the general formula Z1-O-Z2, wherein Z1 is selected from the group comprising CF3CHFCF2-, CF3CF2CF2-, (CF3)2CHCF2-, CF2=C(CF3)-, CF3CF=CF-, CF2=CFCF2-, CF3CH=CF-, CF3CHBrCF2-, CF3CFBrCF2-, or CF2BrCF2- and Z2 is selected from the group comprising -CHF2, -CF3, -CH2CF3, -CH2Br, -CFBr2, or-CF2Br.
Patent NZ-538315-A (NZ)
Title: Method for heating the seat and/or back rest upholstery of a chair pertaining to a chair lift installation, and corresponding chair
Inventor: SEIBT MANFRED
IPC: B61B11/00
Filed: 2004-03-08
Abstract: Disclosed is a method for heating the seat and/or back rest upholstery (4) of a chair pertaining to a chair lift installation, said method being characterised in that the seat and/or back rest upholstery is heated while the chair is in the chair lift station, by means of an electric heating device (7) integrated into the seat and/or back rest upholstery. The disclosure also relates to a corresponding chair comprising an electrically operated heating device (7).
Patent NZ-540292-A (NZ)
Title: Novel inhibitor-resistant HCV NS3 protease comprising a mutated amino acid sequence
Inventor: KUKOLJ GEORGE
IPC: C12N9/50
Filed: 2003-10-24
Abstract: An HCV NS3 protease comprising SEQ ID NO:2 in which at least one of positions 155 or 156 of the amino acid sequence is mutated. The amino acid at position 155 is substituted with glutamine or tryptophan and/or the amino acid at position 156 is substituted with a non-alanine amino acid. An inhibitor-resistant protease is produced as a result of the mutations.
Patent NZ-543100-A (NZ)
Title: Preventive/remedy for retinal nerve dieases containing alkyl ether derivatives or salts thereof
Inventor: KIMURA TATSUO
IPC: A61K31/397
Filed: 2004-04-15
Abstract: Disclosed are alkyl ether derivatives of general formula [1] or its salt which shows an effect of protecting retinal nerve cells and therefore is useful as a preventive and/or a remedy for retinal nerve diseases such as glaucoma, diabetic retinopathy, retinal artery obstruction, retinal venous obstruction, macular degeneration and retinopathy of prematurity.
Patent NZ-545366-A (NZ)
Title: Glutaminyl based DPIV inhibitors
Inventor: DEMUTH HANS-ULRICH
Filed: 2002-06-27
Abstract: An acid addition salt of a compound of the formula (I) is disclosed: wherein X = CH2 or S; and wherein the acid addition salt is selected from the group consisting of salts of hydrobromic, perchioric, nitric, propionic, glycolic, lactic, maleic, malic, citric, benzoic, mandelic, methanesulfonic, hydroxyethanesulfonic, benzenesulfonic, oxalic, pamoic, 2-naphthalenesulfonic, p-toluenesulfonic, cyclohexanesulfamic, salicylic, saccharinic and trifluoroacetic acid. The pharmaceutically acceptable acid addition salt forms of the compound of the formula (I) are useful in treating conditions mediated by dipeptidyl peptidase IV (DPIV) or DPIV-like enzymes, such as arthritis, obesity, immune and autoimmune disorders, allograft transplantation, cancer, neuronal disorders and dermal diseases.
Patent NZ-550046-A (NZ)
Title: Cytotoxicity mediation of cells evidencing surface expression of MCSP
Inventor: YOUNG DAVID S F
IPC: C07K16/00
Filed: 2005-03-23
Abstract: Disclosed is the use of monoclonal antibody encoded by a clone deposited with the ATCC as accession no PTA-5643 for detecting expression of MCSP (melanoma-associated chondroitin sulfate proteoglycan) by a cell in a cell sample by determining binding of said monoclonal antibody with said cell sample. Also disclosed is an assay to determine the expression of MCSP by human cells.
Patent NZ-551388-A (NZ)
Title: Radiant gas burner heater
Inventor: JOHANSSON JOHN
Filed: 2006-11-16
Abstract: A gas heater having a gas burner or burners adapted or adaptable to receive a gas feed and to combust it, at least one radiant member to be heated by the combustion of the gas of the burner(s), a heat shield above at least the gas burner(s), and a housing about the radiant member(s), the gas burner(s) and the heat shield, the housing allowing the radiant member(s) to radiate heat directly out of the front of the housing, wherein the heat shield is set down from the top of the housing within the housing, and wherein there are lateral outlets for combustion gases and a heat exchange airflow through the part of the housing.
Patent NZ-554608-A (NZ)
Title: System and method for an intervertebral implant
Inventor: GEISERT CHRISTOPHE
IPC: A61F2/46
Filed: 2005-09-16
Abstract: An intervertebral disc prothesis has an inlay between upper and lower bearing surfaces and at least one guide slot 11 12 in each of the upper and lower bearing surfaces. The guide slots are formed in such a way that a guide inserted into a guide slot will be held firmly in place.
Patent NZ-563867-A (NZ)
Title: Non-pneumatic vehicle tyre with embedded compound-curve springs
Inventor: MOON MICHAEL
IPC: B60C7/14
Filed: 2006-05-08
Abstract: A non-pneumatic tyre (30) for a vehicle featuring a body of elastic material and having a circumferentially-extending crown portion featuring a running surface and circumferentially-extending sidewalls joined to the crown portion. The side walls terminate in circumferentially-extending beads which are adapted to engage the rim of a vehicle wheel. A number of radially-extending and circumferentially-spaced compound-curve springs (32) made of a composite material are at least partially embedded within the crown portion and the sidewalls. The curved springs have ends terminating within the beads of the tyre body. A circumferentially-extending belt constructed of a high-strength and low stretch material is positioned radially outside of the compound-curve springs. The springs have sidewalls that are generally S-shaped.
Patent NZ-565111-A (NZ)
Title: Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
Inventor: MOLINO BRUCE F
IPC: C07D487/02
Filed: 2006-07-17
Abstract: Disclosed is a benzo[c]azepine of formulae I(A-E) having the following structure: I(A-E) wherein the carbon atom designated * is in the R or S configuration; and X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined in the specification or an oxide thereof, or a pharmaceutically acceptable salt thereof. Also disclosed is the use of said compound in the treatment of lower back pain, attention deficit hyperactivity disorder (ADHD), cognition impairment, anxiety disorders, generalized anxiety disorder (GAD), panic disorder, bipolar disorder or manic depression or manicdepressive disorder, obsessive compulsive disorder (OCD), posttraumatic stress disorder (PTSD), acute stress disorder, social phobia, simple phobias, pre-menstrual dysphoric disorder (PIvIDD), social anxiety disorder (SAD), major depressive disorder (MADD), postnatal depression, dysthymia, depression associated with Alzheimer's disease, Parkinson's disease, or psychosis, supranuclear palsy, eating disorders, obesity, anorexia nervosa, bulimia nervosa, binge eating disorder, analgesia, substance abuse disorders, chemical dependencies, nicotine addiction, cocaine addiction, alcohol and amphetamine addiction, Lesch-Nyhan syndrome, neurodegenerative diseases, Parkinson's disease, late luteal phase syndrome or narcolepsy, psychiatric symptoms, anger, rejection sensitivity, movement disorders, extrapyramidal syndrome, Tic disorders, restless leg syndrome (RLS), tardive dyskinesia, supranuclear palsy, sleep related eating disorder (SRED), night eating syndrome (NBS), stress urinary incontinence (SUI), migraine, neuropathic pain, diabetic neuropathy, fibromyalgia syndrome (FS), chronic fatigue syndrome (CPS), sexual dysfunction, premature ejaculation, male impotence, and thermoregulatory disorders.
Patent NZ-575441-A (NZ)
Title: Programming environment and metadata management for programmable multimedia controller
Inventor: MADONNA ROBERT P
IPC: H04N21/466
Filed: 2007-09-13
Abstract: An apparatus and method for configuring a system, which includes a programmable multimedia controller, is disclosed. The apparatus for configuring the system comprises a memory and a programmed processor. The memory stores a library of components which are available for inclusion in the system, where each of the components has an associated component profile which contains information regarding the component's capabilities. The processor executes a graphical programming environment which includes: a workspace, a drawing tool, and a configuration compiler. A plurality of selected components from the library are placed into the workspace to indicate their inclusion in the system. The drawing tool is used to draw desired connections between particular ones of the selected components, and from particular ones of the selected components and a representation of the programmable multimedia controller, to create a desired configuration. The configuration compiler determines realized programmable services that the programmable multimedia controller is capable of providing to a user based on the selected components and the desired configuration, and displays a list of the realized programmable services to the user.
Patent NZ-576237-A (NZ)
Title: Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
Inventor: BONADEO DANIELE
IPC: A61K31/473
Filed: 2007-10-19
Abstract: Disclosed herein is a soft gelatin capsule for oral administration comprising: a) a soft gelatin outer shell having an oxygen permeability of less than about 1.0 x 10-3 ml cm/(cm2 24 hr atm); and b) a lipophilic liquid inner fill composition comprising: i) greater than about 50wt% of one or more lipophilic components; ii) from about 1 to about 20wt% of water miscibilized or homogenised in said one or more lipophilic components; iii) from about 0.5 to 2.0 mg of palonosetron as palonosetron hydrochloride solubilized or dispersed in said water; and iv) a surfactant; wherein said capsule exhibits pharmacokinetics when orally ingested in a fasted state that are bioequivalent to a formulation having greater than 95% absolute bioavailability, where bioequivalence is established by a 90% confidence interval for AUC which is between 80 and 125%. Also disclosed are methods for optimizing the bioavailability and stability of palonosetron in a palonosetron gelatin capsule and methods of making a batch of palonosetron dosage forms having reduced quantities of impurities and oxygen mediated degradation products.
Patent NZ-578509-A (NZ)
Title: Fertilizer-polymer mixtures which inhibit nitrification in soils
Inventor: SANDERS JOHN LARRY
IPC: C05G3/90
Filed: 2008-01-24
Abstract: Disclosed is an aqueous fertilizer polymer mixture having a pH of up to about 2, which includes the acid or partial salt form of a copolymer having a general formula as disclosed in the specification, wherein the substituents are also disclosed in the specification. Also disclosed is a method of applying the said polymer mixture to soil.
Patent NZ-585822-A (NZ)
Title: An exersise machine using gyroscopic forces, the gyro set in motion by a retractable pull cord
Inventor: SMITH TOM
IPC: A63B21/22
Filed: 2010-06-01
Abstract: A gyroscopic exercise (400) device with a retractable manual starting cord (401) is disclosed. The device has a gyroscopic rotor (428) comprising a rotor balanced around a primary axis of rotation, and a secondary axis of precession. The rotor is within a housing (12) for protecting it from inadvertent physical contact by a user while permitting limited access to the gyroscopic rotor during a manual gyroscopic pull start.
Patent NZ-588900-A (NZ)
Title: Quinazoline derivatives for inhibiting vascular endothelial growth factor receptor activity
Inventor: SU WEI-GUO
IPC: C07D239/72
Filed: 2009-05-08
Abstract: Disclosed herein are quinazoline derivatives of general formula (I) in which: each of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, independently, is H, halo, nitro, amino, cyano, hydroxy, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, alkoxy, alkylthio, alkylcarbonyl, carboxy, alkoxycarbonyl, carbonylamino, sulfonylamino, aminocarbonyl, or aminosulfonyl, or R3 and R4, together with the carbon atoms to which they are attached, form a 4- to 7- membered saturated, unsaturated, or aromatic ring, optionally containing 1-3 hetero atoms selected from N, O and S; X is O, S, or NR, wherein R is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, heteroaryl, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, or aminosulfonyl; and Z is N; for inhibiting vascular endothelial growth factor receptor activity, for use in the treatment of an angiogenesis-related disorder, such as cancer, age-related macula degeneration, or chronic inflammatory disease.
Patent NZ-594376-A (NZ)
Title: A showerhead for dispensing an aerated jet of water, wherein water flow through the shower head draws in air by Venturi effect via air intake holes
Inventor: MORBIO ALBERTO
IPC: B05B1/18
Filed: 2010-02-23
Abstract: 594376 A device (1) for dispensing an aerated jet of water, such as a shower head, is disclosed. The device comprises an outer casing (10), a dispenser plate (14) and an intermediate plate (18). The dispenser plate closes the outer casing in and comprises a plurality of outlet nozzles (16) for dispensing the aerated jets of water. The intermediate plate is positioned in the casing so as to define a water inlet chamber, in communication with a water supply duct (21), and a water outlet chamber, in communication with the outlet nozzles. The intermediate plate is also provided with an air-water mixing chamber in communication with the water inlet chamber through a plurality of water inlet holes and with the outside environment through a number of air intake holes (30) and with the water outlet chamber through a plurality of aerated water outlet holes (32). The air intake holes are made in respective air intake pipes (31) which extend from the intermediate plate and which are inserted in respective holes (33, 33') in the dispenser plate. The air intake pipes and the outlet holes of the aerated water are formed in an annular element (36) sealed tight to the intermediate plate. The flow of water through the air-water mixing chamber causes air to be drawn into the chamber by Venturi effect, thus aerating the water. The aerated water then enters the water outlet chamber, fills it up and is sprayed out the outlet nozzles.
Patent NZ-595465-A (NZ)
Title: Light panel with detachable LED strips
Inventor: MITCHELL THOMAS LESLIE
IPC: F21V19/04
Filed: 2011-09-29
Abstract: 595465 Disclosed is a light panel. The light panel includes a support surface (70), a plurality of electrical connectors and a plurality of light-emitting diode (LED) strips (60). The electrical connectors are supported by the support surface (70). The plurality of light emitting diode (LED) strips (60) each include a plurality of light emitting diodes. At least some of the LED strips (60) are releasably connected to a respective electrical connector. One or more of the LED strips (60) are further releasably and directly connected to the support surface (70).
Patent NZ-596012-A (NZ)
Title: Truck mounted moble pulsed flash x-ray irradiator
Inventor: BIRNBACH CURTIS A
IPC: A61L2/00
Filed: 2009-05-18
Abstract: A truck or vehicle mounted apparatus for Flash X-ray irradiation of material for sterilization includes a Flash X-ray source comprised of an electron gun and an anode. The electron gun comprises a field emission cold cathode having an electron emitting surface, and a grid for controlling electron flow from the cathode to the anode. The anode has an electron-receiving main surface and an X-ray emitting, oppositely facing main surface. The X-ray emitting surface, emits X-radiation into an irradiation volume. The X-ray emitting surface of the anode has orthogonally oriented first and second dimensions of greater than 2 millimetres each. A high voltage pulse power supply, connected to the vehicle's electricity generator and with a supplemental energy storage capacitor, powers the Flash X-ray source. The cathode, grid and anode are located in a high vacuum housing. The electron gun, anode and high voltage pulse power supply are constructed as to create X-radiation in said irradiation volume to achieve a measured level of irradiation of the material in the irradiation volume as measured by a sensor. The material to be irradiated is moved through the high vacuum chamber by the vehicle mounted venturi pump. A turbojet powers both the electricity generator and vacuum pump.
Patent NZ-600830-A (NZ)
Title: A staff number optimisation system using projected visitor numbers to determine required staff number to achieve desired profit levels and conversion rates
Inventor: CORRICK DAVID WAYNE
IPC: G06Q10/04
Filed: 2012-06-22
Abstract: Disclosed is a rostering system for setting staff levels in a customer service business. The system is configured such that a computer system (1) receives or records data (2) identifying at least the approximate number of customer visitors to the business (3) for a number of periods of time. The computer system (1) also receives or records data indicative of sales achieved for each period of time (7) and the number of staff working at the business for each period of time (6). The computer system (1) processes all of the above data (4, 6, 7) to determine the relative sales success of the business (3) based on the ratio of customer visitors to staff for each period of time. Using the determinations at d) above, the computer system (1) predicts the number of staff that should be rostered for optimal sales success for each period of time. The computer system (1) then reports the above predictions.
Patent NZ-603650-A (NZ)
Title: Feeder for feeding document to document imaging system and method for feeding documents
Inventor: MILLER GARY
IPC: G06F15/00
Filed: 2011-04-19
Abstract: An apparatus for processing documents, comprises a feeder 30 operable to receive a packet of a plurality of documents and separate the documents to serially feed the documents away from the feeder 30, a generally horizontal transport configured to receive a transaction of documents dropped onto a surface of the transport and convey the transaction of documents toward the feeder 30, a pre-singulator disposed between the horizontal transport and the feeder 30, and a sensor for detecting whether the number of documents in the transaction exceeds a predetermined threshold that is greater than zero. The pre-singulator comprises an upper roller and a lower roller forming a nip for receiving the documents from the horizontal transport, and a selectively actuable brake for selectively braking the forward movement of the lower roller of the pre-singulator in response to the sensor detecting the characteristic of the transaction.
Patent NZ-612010-A (NZ)
Title: Oligonucleotide probe set and methods of microbiota profiling
Inventor: VEBØ Heidi
IPC: C12Q1/68
Filed: 2011-12-16
Abstract: Disclosed is a set of oligonucleotide probes comprising oligonucleotides of up to 100 nucleotides of the sequences as defined in the specification. Also disclosed is the use of the probe set for profiling the microbiota of the GI tract of a subject.